Baxter Heparin Injection Recall: Microbial Contamination Risk
Baxter recalls 1000mL heparin injections with microbial contamination risk. Out of limit endotoxin test results found in specific lots. Stop using if you have this product.
Use caution until it’s fixed
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Contact the company
What happened, in plain English
Baxter is recalling 1000mL heparin injections that tested positive for microbial contamination and endotoxin levels outside acceptable limits. This could cause infections or adverse reactions if used improperly. Read more at govinfonow.com/recall/32575-baxter-heparin-injection-recall-microbial-contamination-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/32575-baxter-heparin-injection-recall-microbial-contamination-risk · Updated September 23, 2026 · FDA enforcement record: FDA #D-0649-2024
Cite this page
“Baxter Heparin Injection Recall: Microbial Contamination Risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/32575-baxter-heparin-injection-recall-microbial-contamination-risk. Based on FDA recall #D-0649-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0649-2024%22&limit=1).
Why it’s dangerous
The heparin injections were found to have microbial contamination and endotoxin levels exceeding safety limits. This can lead to infections or adverse reactions when administered to patients.
Who’s affected
Healthcare professionals and patients who have the specific lot number of this heparin injection are affected. Those using the product for medical treatments are at risk of infection or adverse reactions.
How to tell if you have this one
Check for the lot number N008235 with expiration date 8/31/2024 on the 1000mL sterile single-dose container. This product is labeled as Rx Only and sold by Baxter Healthcare Corporation.
- Brand
Baxter- Category
Drug
What to do — step by step
Check Product Details
Look for the lot number N008235 with expiration date 8/31/2024 on the 1000mL sterile single-dose container.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 41 days after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Baxter recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0649-2024 (August 1, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0649-2024 to see it in context.
- Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.